Outcomes Research & Evaluation Home	Outcomes Research Area	Prior Authorization Unit	Provider Update
Disease Management	Disease Surveillance	Presentations	Links & Conferences

---

Provider Update Articles

2004

2003

2002

2001

2000

2004

November-December, Vol. 21, No. 6, Chronic Obstructive Pulmonary Disease (COPD), W. Greg Leader, Pharm.D.

September-October, Vol. 21, No. 5, Hepatitis C Treatment and Monitoring, W. Greg Leader, Pharm.D., Anand Dalal, Ph.D. Candidate

July-August, Vol. 21, No. 4, Hepatitis C Testing and Prevalence, W. Greg Leader, Pharm.D., Anand Dalal, Ph.D. Candidate

May-June, Vol. 21, No. 3, Issues in Pain Management, Gina C. Biglane, Pharm.D.

March-April, Vol. 21, No. 2, Age-Related Macular Degeneration: Past, Present & Future, Lisa Digioia-Ross, Pharm.D.; Robert D. Ross, M.D., FACS

January-February, Vol. 21, No. 1, Inappropriate Prescribing in the Elderly, Melissa L. Dear, BS Pharm.

2003

August-October, Vol. 20, No. 4, Low Molecular Weight Heparin in the Treatment of Deep Vein Thrombosis: Bridging the Gap to Better Outcomes, Martin B. Steffenson, Pharm.D.; Summer C. Helo, Pharm.D. Candidate; September E. Lee, Pharm.D. Candidate; Michael S. D. Huynh, Pharm.D. Candidate

June-July, Vol. 20, No. 3, Glucocorticosteroids andn Osteoporosis, Bill Ross, BS Pharm.

April-May, Vol. 20, No. 2, Attention Deficit Hyperactivity Disorder (ADHD) in the Louisiana Medicaid Population: Prevalence, Demographic and Clinical Characteristics, Larry J. Humber, R.Ph.; Gina C. Biglane, Pharm.D.; Sandra G. Blake, Ph.D.

February-March, Vol. 20, No. 1, Guidelines for the Treatment of High Cholesterol: A Review, W. Greg Leader, Pharm.D.

2002

December-January 2003, Vol. 19, No. 6, New Oral Pharmacologic Options in the Treatment of Overactive Bladder: Focus on the Antimuscarinic Agents, Nicole Robin Krohn, Pharm.D.

October-November, Vol. 19, No. 5, Vitamin Use in Adults, Charles W. Jastram, Jr., Pharm.D.

August-September, Vol. 19, No. 4, Pediatric Drug Dosing, Ahmad Khalil, Pharm.D.; C. David Matthews, Pharm.D.

June-July, Vol. 19, No. 3, Treating Hypertension in the Patient with Diabetes: Revised Goals & Medication Management, Justin J. Sherman, Pharm.D.

April-May, Vol. 19, No. 2, Who Defines "Quality of Life?", Lesa W. Lawrence, Ph.D.

February-March, Vol. 19, No. 1, An Introduction to Pharmacoeconomics, Sandra G. Blake, Ph.D.

2001

December-January 2002, Vol. 18, No. 6, Glaucoma 2001: An Overview with Emphasis on Medical Management, Lisa M. Digioia-Ross, Pharm.D.

October-November, Vol. 18, No. 5, Selection of Antipsychotics in the Elderly: A Focus on the Atypical Antipsychotics, J. Lance Nickelson, Pharm.D.

August-September, Vol. 18, No. 4, Acetaminophen Toxicity, Mark Ryan, R.Ph, CSPI

June-July, Vol. 18, No. 3, Hepatitis C: The Silent Killer, W. Greg Leader, Pharm.D.

April-May, Vol. 18, No. 2, Treatment of HIV Infection: An Overview-Part II, Nancy M. Toedter, Pharm.D.

February-March, Vol. 18, No. 1, Treatment of HIV Infcetion: An Overview-Part I, Nancy M. Toedter, Pharm.D.

2000

December-January 2001, Vol. 17, No. 6, Appropriate Use of Prescription Antisecretory Agents in Acid-Related Diseases, Shanna Thibodeaux, Pharm.D.

October-November, Vol. 17, No. 5, Acute Otitis Media: Management and Prevention of Resistance, Cathy Whipple, R.Ph.

August-September, Vol. 17, No. 4, Cardiovascular Disease in Women, J. Christopher Lynch, Pharm.D.

June-July, Vol. 17, No. 3, Smoking Cessation: Basic Strategies to Foster and Assist Patients to Stop Smoking Tobacco, Martin B. Steffenson, Pharm.D.; Siddarthan Ilangovan, M. Pharm.

February-March, Vol. 17, No. 1, Urinary Tract Infections, Nancy M. Toedter, Pharm.D.

December-2000 January, Vol. 16, No. 6, Appropriate Use of H2-Antagonistst and Proton Pump Inhibitors for Managing Gastrointestinal Disorders, Satha A. Al-Samarrai, Pharm.D., W. Greg Leader, Pharm.D.